|
CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering
PharmiWeb.com (press release) CEL-SCI Corporation (NYSE MKT: CVM) a late-stage oncology company has agreed to sell common stock and warrants in a registered direct offering to European investors at a combined price of $0.76 for aggregate gross proceeds of a little over $1 million. Stocks on the Move: CEL-SCI Corporation (NYSEMKT:CVM), Illumina, Inc …Street Newswire (registration) Traders Favorite: CEL-SCI Corporation (NYSEAMEX:CVM), Illumina, Inc …Market News Call |
